{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:33:05Z","timestamp":1794709985146,"version":"4.9.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I21BX003807"],"award-info":[{"award-number":["I21BX003807"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IO1 BX003527"],"award-info":[{"award-number":["IO1 BX003527"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I21BX002215"],"award-info":[{"award-number":["I21BX002215"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1R01AG063913"],"award-info":[{"award-number":["1R01AG063913"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pathological analysis of brain tissue from animals and humans with a history of traumatic brain injury (TBI) suggests that TBI could be one of the risk factors facilitating onset of dementia with possible Alzheimer\u2019s disease (AD), but medications to prevent or delay AD onset are not yet available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study explores four medication classes (angiotensin-converting enzyme inhibitors (ACEI), beta blockers, metformin, and statins) approved by the Food and Drug Administration (FDA) for other indications and evaluates their influence when used in combination on the risk of possible AD development for patients with a history of TBI. We identified patients with history of TBI from an existing Department of Veterans Affairs (VA) national database. Among 1,660,151 veterans who used VA services between the ages of 50 to 89\u2009years old, we analyzed 733,920 patients, including 15,450 patients with a history of TBI and 718,470 non-TBI patients. The TBI patients were followed for up to 18.5\u2009years, with an average of 7.7\u2009\u00b1\u20094.7\u2009years, and onset of dementia with possible AD was recorded based on International Statistical Classification of Diseases (ICD) 9 or 10 codes. The effect of TBI on possible AD development was evaluated by multivariable logistic regression models adjusted by age, gender, race, and other comorbidities. The association of ACEI, beta blockers, metformin, statins, and combinations of these agents over time from the first occurrence of TBI to possible AD onset was assessed using Cox proportional hazard models adjusted for demographics and comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Veterans with at least two TBI occurrences by claims data were 25% (odds ratio (OR)\u2009=\u20091.25, 95% confidence intervals (CI) (1.13, 1.37)) more likely to develop dementia with possible AD, compared to those with no record of TBI. In multivariable logistic regression models (propensity score weighted or adjusted), veterans taking a combination of ACEI and statins had reduced risk in developing possible AD after suffering TBI, and use of this medication class combination was associated with a longer period between TBI occurring and dementia with possible AD onset, compared to patients who took statins alone or did not take any of the four target drugs after TBI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The combination of ACEI and statins significantly lowered the risk of development of dementia with possible AD in a national cohort of people with a history of TBI, thus supporting a clinical approach to lowering the risk of dementia with possible AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-020-00589-3","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T15:02:46Z","timestamp":1585321366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer\u2019s disease after traumatic brain injury"],"prefix":"10.1186","volume":"12","author":[{"given":"Mingfei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Reisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Morris-Eppolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley X.","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis E.","family":"Kazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wolozin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee E.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,27]]},"reference":[{"issue":"340","key":"589_CR1","doi-asserted-by":"publisher","first-page":"b5465","DOI":"10.1136\/bmj.b5465","volume":"340","author":"NC Li","year":"2010","unstructured":"Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ. 2010;340(340):b5465.","journal-title":"BMJ."},{"issue":"2","key":"589_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/1470320312459977","volume":"14","author":"B Singh","year":"2013","unstructured":"Singh B, Sharma B, Jaggi AS, Singh N. Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-gamma agonistic property. J Renin-Angiotensin-Aldosterone Syst. 2013;14(2):124\u201336.","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"20","key":"589_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1741-7015-5-20","volume":"5","author":"B Wolozin","year":"2007","unstructured":"Wolozin B, Wang SW, Li NC, Lee A, Lee TA, Kazis LE. Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med. 2007;5(20):20.","journal-title":"BMC Med"},{"issue":"2","key":"589_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/JAD-2010-101179","volume":"23","author":"S Sierra","year":"2011","unstructured":"Sierra S, Ramos MC, Molina P, Esteo C, Vazquez JA, Burgos JS. Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. J Alzheimers Dis. 2011;23(2):307\u201318.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"589_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/JGP.0b013e318181276a","volume":"16","author":"PB Rosenberg","year":"2008","unstructured":"Rosenberg PB, Mielke MM, Tschanz J, Cook L, Corcoran C, Hayden KM, et al. Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. Am J Geriatr Psychiatry. 2008;16(11):883\u201392.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"589_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.pbb.2012.03.002","volume":"101","author":"J Li","year":"2012","unstructured":"Li J, Deng J, Sheng W, Zuo Z. Metformin attenuates Alzheimer\u2019s disease-like neuropathology in obese, leptin-resistant mice. Pharmacol Biochem Behav. 2012;101(4):564\u201374.","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"589_CR7","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3233\/JAD-181240","volume":"68","author":"SA Farr","year":"2019","unstructured":"Farr SA, Roesler E, Niehoff ML, Roby DA, McKee A, Morley JE. Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer\u2019s disease. J Alzheimers Dis. 2019;68(4):1699\u2013710.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"589_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/HTR.0b013e31819581d8","volume":"24","author":"H Terrio","year":"2009","unstructured":"Terrio H, Brenner LA, Ivins BJ, Cho JM, Helmick K, Schwab K, et al. Traumatic brain injury screening: preliminary findings in a US Army brigade combat team. J Head Trauma Rehabil. 2009;24(1):14\u201323.","journal-title":"J Head Trauma Rehabil"},{"issue":"5","key":"589_CR9","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awv038","volume":"138","author":"CL Mac Donald","year":"2015","unstructured":"Mac Donald CL, Adam OR, Johnson AM, Nelson EC, Werner NJ, Rivet DJ, et al. Acute post-traumatic stress symptoms and age predict outcome in military blast concussion. Brain. 2015;138(5):1314\u201326.","journal-title":"Brain."},{"issue":"12","key":"589_CR10","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/aje\/kwn068","volume":"167","author":"AI Schneiderman","year":"2008","unstructured":"Schneiderman AI, Braver ER, Kang HK. Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: persistent postconcussive symptoms and posttraumatic stress disorder. Am J Epidemiol. 2008;167(12):1446\u201352.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"589_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.psc.2013.11.005","volume":"37","author":"RE Jorge","year":"2014","unstructured":"Jorge RE, Arciniegas DB. Mood disorders after TBI. Psychiatr Clin North Am. 2014;37(1):13\u201329.","journal-title":"Psychiatr Clin North Am"},{"issue":"7","key":"589_CR12","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.sleep.2012.04.006","volume":"13","author":"JL Mathias","year":"2012","unstructured":"Mathias JL, Alvaro PK. Prevalence of sleep disturbances, disorders, and problems following traumatic brain injury: a meta-analysis. Sleep Med. 2012;13(7):898\u2013905.","journal-title":"Sleep Med"},{"issue":"7","key":"589_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/jnnp.74.7.857","volume":"74","author":"S Fleminger","year":"2003","unstructured":"Fleminger S, Oliver DL, Lovestone S, Rabe-Hesketh S, Giora A. Head injury as a risk factor for Alzheimer\u2019s disease: the evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry. 2003;74(7):857\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"20","key":"589_CR14","doi-asserted-by":"publisher","first-page":"e1771","DOI":"10.1212\/WNL.0000000000005522","volume":"90","author":"RC Gardner","year":"2018","unstructured":"Gardner RC, Byers AL, Barnes DE, Li Y, Boscardin J, Yaffe K. Mild TBI and risk of Parkinson disease: a chronic effects of neurotrauma consortium study. Neurology. 2018;90(20):e1771\u2013e9.","journal-title":"Neurology."},{"issue":"4","key":"589_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1212\/WNL.0000000000000616","volume":"83","author":"DE Barnes","year":"2014","unstructured":"Barnes DE, Kaup A, Kirby KA, Byers AL, Diaz-Arrastia R, Yaffe K. Traumatic brain injury and risk of dementia in older veterans. Neurology. 2014;83(4):312\u20139.","journal-title":"Neurology."},{"issue":"11","key":"589_CR16","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/jnnp-2012-302633","volume":"83","author":"HK Wang","year":"2012","unstructured":"Wang HK, Lin SH, Sung PS, Wu MH, Hung KW, Wang LC, et al. Population based study on patients with traumatic brain injury suggests increased risk of dementia. J Neurol Neurosurg Psychiatry. 2012;83(11):1080\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"589_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/oxfordjournals.aje.a115523","volume":"131","author":"AB Graves","year":"1990","unstructured":"Graves AB, White E, Koepsell TD, Reifler BV, van Belle G, Larson EB, et al. The association between head trauma and Alzheimer's disease. Am J Epidemiol. 1990;131(3):491\u2013501.","journal-title":"Am J Epidemiol"},{"issue":"Suppl 2","key":"589_CR18","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/ije\/20.Supplement_2.S28","volume":"20","author":"JA Mortimer","year":"1991","unstructured":"Mortimer JA, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, et al. Head trauma as a risk factor for Alzheimer\u2019s disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol. 1991;20(Suppl 2):S28\u201335.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"589_CR19","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1212\/WNL.54.6.1316","volume":"54","author":"Z Guo","year":"2000","unstructured":"Guo Z, Cupples LA, Kurz A, Auerbach SH, Volicer L, Chui H, et al. Head injury and the risk of AD in the MIRAGE study. Neurology. 2000;54(6):1316\u201323.","journal-title":"Neurology."},{"issue":"5","key":"589_CR20","doi-asserted-by":"publisher","first-page":"e62422","DOI":"10.1371\/journal.pone.0062422","volume":"8","author":"YK Lee","year":"2013","unstructured":"Lee YK, Hou SW, Lee CC, Hsu CY, Huang YS, Su YC. Increased risk of dementia in patients with mild traumatic brain injury: a nationwide cohort study. PLoS One. 2013;8(5):e62422.","journal-title":"PLoS One"},{"issue":"4","key":"589_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/01.wad.0000213865.09806.92","volume":"20","author":"JC Morris","year":"2006","unstructured":"Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, et al. The uniform data set (UDS): clinical and cognitive variables and descriptive data from Alzheimer disease centers. Alzheimer Dis Assoc Disord. 2006;20(4):210\u20136.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"589_CR22","first-page":"270","volume":"18","author":"DL Beekly","year":"2004","unstructured":"Beekly DL, Ramos EM, van Belle G, Deitrich W, Clark AD, Jacka ME, et al. The National Alzheimer\u2019s coordinating center (NACC) database: an Alzheimer disease database. Alzheimer Dis Assoc Disord. 2004;18(4):270\u20137.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"589_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3233\/JAD-143207","volume":"47","author":"MF Mendez","year":"2015","unstructured":"Mendez MF, Paholpak P, Lin A, Zhang JY, Teng E. Prevalence of traumatic brain injury in early versus late-onset Alzheimer\u2019s disease. J Alzheimers Dis. 2015;47(4):985\u201393.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"589_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.rehab.2017.03.009","volume":"60","author":"J Julien","year":"2017","unstructured":"Julien J, Joubert S, Ferland MC, Frenette LC, Boudreau-Duhaime MM, Malo-Veronneau L, et al. Association of traumatic brain injury and Alzheimer disease onset: a systematic review. Ann Phys Rehabil Med. 2017;60(5):347\u201356.","journal-title":"Ann Phys Rehabil Med"},{"issue":"10","key":"589_CR25","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1089\/neu.2005.22.1134","volume":"22","author":"Y Yoshiyama","year":"2005","unstructured":"Yoshiyama Y, Uryu K, Higuchi M, Longhi L, Hoover R, Fujimoto S, et al. Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse model. J Neurotrauma. 2005;22(10):1134\u201341.","journal-title":"J Neurotrauma"},{"issue":"134","key":"589_CR26","doi-asserted-by":"publisher","first-page":"134ra60","DOI":"10.1126\/scitranslmed.3003716","volume":"4","author":"LE Goldstein","year":"2012","unstructured":"Goldstein LE, Fisher AM, Tagge CA, Zhang X-L, Velisek L, Sullivan JA, et al. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med. 2012;4(134):134ra60.","journal-title":"Sci Transl Med"},{"issue":"2","key":"589_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3233\/JAD-130182","volume":"37","author":"BR Huber","year":"2013","unstructured":"Huber BR, Meabon JS, Martin TJ, Mourad PD, Bennett R, Kraemer BC, et al. Blast exposure causes early and persistent aberrant phospho- and cleaved-tau expression in a murine model of mild blast-induced traumatic brain injury. J Alzheimers Dis. 2013;37(2):309\u201323.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"589_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/brain\/awx350","volume":"141","author":"CA Tagge","year":"2018","unstructured":"Tagge CA, Fisher AM, Minaeva OV, Gaudreau-Balderrama A, Moncaster JA, Zhang XL, et al. Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse model. Brain. 2018;141(2):422\u201358.","journal-title":"Brain."},{"issue":"9","key":"589_CR29","first-page":"2685","volume":"141","author":"ER Zanier","year":"2018","unstructured":"Zanier ER, Bertani I, Sammali E, Pischiutta F, Chiaravalloti MA, Vegliante G, et al. Induction of a transmissible tau pathology by traumatic brain injury. Brain. 2018;141(9):2685\u201399.","journal-title":"Brain."},{"issue":"2","key":"589_CR30","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3233\/JAD-180726","volume":"66","author":"M Chen","year":"2018","unstructured":"Chen M, Song H, Cui J, Johnson CE, Hubler GK, DePalma RG, et al. Proteomic profiling of mouse brains exposed to blast-induced mild traumatic brain injury reveals changes in axonal proteins and phosphorylated tau. J Alzheimers Dis. 2018;66(2):751\u201373.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"589_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s40478-016-0395-3","volume":"4","author":"JA Goodrich","year":"2016","unstructured":"Goodrich JA, Kim JH, Situ R, Taylor W, Westmoreland T, Du F, et al. Neuronal and glial changes in the brain resulting from explosive blast in an experimental model. Acta Neuropathol Commun. 2016;4(1):124.","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"589_CR32","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1089\/neu.2018.5720","volume":"36","author":"B Mouzon","year":"2019","unstructured":"Mouzon B, Bachmeier C, Ojo J, Acker C, Ferguson S, Crynen G, et al. Chronic white matter degeneration, but no tau pathology at one-year post-repetitive mild traumatic brain injury in a tau transgenic model. J Neurotrauma. 2019;36(4):576\u201388.","journal-title":"J Neurotrauma"},{"issue":"7561","key":"589_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature14658","volume":"523","author":"A Kondo","year":"2015","unstructured":"Kondo A, Shahpasand K, Mannix R, Qiu J, Moncaster J, Chen CH, et al. Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. Nature. 2015;523(7561):431\u20136.","journal-title":"Nature."},{"issue":"1","key":"589_CR34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s41467-017-01068-4","volume":"8","author":"O Albayram","year":"2017","unstructured":"Albayram O, Kondo A, Mannix R, Smith C, Tsai CY, Li C, et al. Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae. Nat Commun. 2017;8(1):1000.","journal-title":"Nat Commun"},{"issue":"3","key":"589_CR35","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ana.23964","volume":"74","author":"PA Boyle","year":"2013","unstructured":"Boyle PA, Wilson RS, Yu L, Barr AM, Honer WG, Schneider JA, et al. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol. 2013;74(3):478\u201389.","journal-title":"Ann Neurol"},{"issue":"1","key":"589_CR36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.trci.2016.09.002","volume":"3","author":"GD Rabinovici","year":"2017","unstructured":"Rabinovici GD, Carrillo MC, Forman M, DeSanti S, Miller DS, Kozauer N, et al. Multiple comorbid neuropathologies in the setting of Alzheimer\u2019s disease neuropathology and implications for drug development. Alzheimers Dement (N Y). 2017;3(1):83\u201391.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"589_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00702-017-1810-z","volume":"125","author":"P Alexopoulos","year":"2018","unstructured":"Alexopoulos P, Roesler J, Werle L, Thierjung N, Lentzari I, Ortner M, et al. Fluid biomarker agreement and interrelation in dementia due to Alzheimer\u2019s disease. J Neural Transm (Vienna). 2018;125(2):193\u2013201.","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"589_CR38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/WCO.0b013e32834cd477","volume":"24","author":"BE Gavett","year":"2011","unstructured":"Gavett BE, Cantu RC, Shenton M, Lin AP, Nowinski CJ, McKee AC, et al. Clinical appraisal of chronic traumatic encephalopathy: current perspectives and future directions. Curr Opin Neurol. 2011;24(6):525\u201331.","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"589_CR39","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1750-3639.2011.00513.x","volume":"22","author":"VE Johnson","year":"2012","unstructured":"Johnson VE, Stewart W, Smith DH. Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol. 2012;22(2):142\u20139.","journal-title":"Brain Pathol"},{"issue":"9","key":"589_CR40","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jamaneurol.2016.1948","volume":"73","author":"PK Crane","year":"2016","unstructured":"Crane PK, Gibbons LE, Dams-O'Connor K, Trittschuh E, Leverenz JB, Keene CD, et al. Association of traumatic brain injury with late-life neurodegenerative conditions and neuropathologic findings. JAMA Neurol. 2016;73(9):1062\u20139.","journal-title":"JAMA Neurol"},{"issue":"3","key":"589_CR41","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3233\/JAD-2009-1180","volume":"18","author":"JA Sonnen","year":"2009","unstructured":"Sonnen JA, Larson EB, Haneuse S, Woltjer R, Li G, Crane PK, et al. Neuropathology in the adult changes in thought study: a review. J Alzheimers Dis. 2009;18(3):703\u201311.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"589_CR42","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/NEN.0b013e31822e8ae9","volume":"70","author":"KS SantaCruz","year":"2011","unstructured":"SantaCruz KS, Sonnen JA, Pezhouh MK, Desrosiers MF, Nelson PT, Tyas SL. Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun study and the adult changes in thought study. J Neuropathol Exp Neurol. 2011;70(10):832\u201340.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"589_CR43","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2174\/156720512801322573","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS. Overview and findings from the religious orders study. Curr Alzheimer Res. 2012;9(6):628\u201345.","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"589_CR44","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2174\/156720512801322663","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS. Overview and findings from the rush memory and aging project. Curr Alzheimer Res. 2012;9(6):646\u201363.","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"589_CR45","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jalz.2018.12.015","volume":"15","author":"MA Sugarman","year":"2019","unstructured":"Sugarman MA, McKee AC, Stein TD, Tripodis Y, Besser LM, Martin B, et al. Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementia. Alzheimers Dement. 2019;15(5):686\u201398.","journal-title":"Alzheimers Dement"},{"key":"589_CR46","first-page":"187","volume":"34","author":"D Cox","year":"1972","unstructured":"Cox D. Regression models and life tables. Breakthroughs Stat. 1972;34:187\u2013220.","journal-title":"Breakthroughs Stat"},{"issue":"19","key":"589_CR47","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1212\/01.wnl.0000334278.11022.42","volume":"71","author":"EP Helzner","year":"2008","unstructured":"Helzner EP, Scarmeas N, Cosentino S, Tang MX, Schupf N, Stern Y. Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Neurology. 2008;71(19):1489\u201395.","journal-title":"Neurology."},{"key":"589_CR48","first-page":"1","volume":"27","author":"SL Burke","year":"2017","unstructured":"Burke SL, Cadet T, Alcide A, O'Driscoll J, Maramaldi P. Psychosocial risk factors and Alzheimer\u2019s disease: the associative effect of depression, sleep disturbance, and anxiety. Aging Ment Health. 2017;27:1\u20138.","journal-title":"Aging Ment Health"},{"issue":"1","key":"589_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/biomet\/54.1-2.167","volume":"54","author":"SH Walker","year":"1967","unstructured":"Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika. 1967;54(1):167\u201379.","journal-title":"Biometrika."},{"issue":"1","key":"589_CR50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/oxfordjournals.aje.a009034","volume":"145","author":"EL Korn","year":"1997","unstructured":"Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997;145(1):72\u201380.","journal-title":"Am J Epidemiol"},{"issue":"282","key":"589_CR51","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"ELPM Kaplan","year":"2012","unstructured":"Kaplan ELPM. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 2012;53(282):457\u201381.","journal-title":"J Am Stat Assoc"},{"issue":"11","key":"589_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR. Donald. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(11):41\u201355.","journal-title":"Biometrika."},{"issue":"6","key":"589_CR53","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1046\/j.1468-1331.2001.00322.x","volume":"8","author":"KA Jellinger","year":"2001","unstructured":"Jellinger KA, Paulus W, Wrocklage C, Litvan I. Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer\u2019s disease. Eur J Neurol. 2001;8(6):707\u201310.","journal-title":"Eur J Neurol"},{"issue":"5","key":"589_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2217\/nmt-2016-0017","volume":"6","author":"K Dams-O\u2019Connor","year":"2016","unstructured":"Dams-O\u2019Connor K, Guetta G, Hahn-Ketter AE, Fedor A. Traumatic brain injury as a risk factor for Alzheimer's disease: current knowledge and future directions. Neurodegener Dis Manag. 2016;6(5):417\u201329.","journal-title":"Neurodegener Dis Manag"},{"issue":"2","key":"589_CR55","doi-asserted-by":"publisher","first-page":"e0212293","DOI":"10.1371\/journal.pone.0212293","volume":"14","author":"G Weinstein","year":"2019","unstructured":"Weinstein G, Davis-Plourde KL, Conner S, Himali JJ, Beiser AS, Lee A, et al. Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer\u2019s disease: pooled analysis from 5 cohorts. PLoS One. 2019;14(2):e0212293.","journal-title":"PLoS One"},{"issue":"3","key":"589_CR56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"589_CR57","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):270\u20139.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"589_CR58","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"2\u20133","key":"589_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0014-2999(91)90584-D","volume":"200","author":"NM Barnes","year":"1991","unstructured":"Barnes NM, Cheng CH, Costall B, Naylor RJ, Williams TJ, Wischik CM. Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer\u2019s disease. Eur J Pharmacol. 1991;200(2\u20133):289\u201392.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"589_CR60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1365-2990.2007.00885.x","volume":"34","author":"JS Miners","year":"2008","unstructured":"Miners JS, Ashby E, Van Helmond Z, Chalmers KA, Palmer LE, Love S, et al. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer\u2019s disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathol Appl Neurobiol. 2008;34(2):181\u201393.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"589_CR61","first-page":"163","volume":"1","author":"S Miners","year":"2009","unstructured":"Miners S, Ashby E, Baig S, Harrison R, Tayler H, Speedy E, et al. Angiotensin-converting enzyme levels and activity in Alzheimer\u2019s disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am J Transl Res. 2009;1(2):163\u201377.","journal-title":"Am J Transl Res"},{"issue":"5","key":"589_CR62","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","volume":"63","author":"AS Khachaturian","year":"2006","unstructured":"Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, et al. Antihypertensive medication use and incident Alzheimer disease: the Cache County study. Arch Neurol. 2006;63(5):686\u201392.","journal-title":"Arch Neurol"},{"issue":"10","key":"589_CR63","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","volume":"57","author":"B Wolozin","year":"2000","unstructured":"Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme a reductase inhibitors. Arch Neurol. 2000;57(10):1439\u201343.","journal-title":"Arch Neurol"},{"issue":"11","key":"589_CR64","doi-asserted-by":"publisher","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","volume":"95","author":"M Simons","year":"1998","unstructured":"Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A. 1998;95(11):6460\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"589_CR65","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1006\/nbdi.2001.0422","volume":"8","author":"LM Refolo","year":"2001","unstructured":"Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas-Bryant T, et al. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2001;8(5):890\u20139.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"589_CR66","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1073\/pnas.081620098","volume":"98","author":"K Fassbender","year":"2001","unstructured":"Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, et al. Simvastatin strongly reduces levels of Alzheimer\u2019s disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A. 2001;98(10):5856\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"589_CR67","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012;11(11):1006\u201312.","journal-title":"Lancet Neurol"},{"issue":"4","key":"589_CR68","first-page":"243","volume":"3","author":"H Hampel","year":"2016","unstructured":"Hampel H, O'Bryant SE, Castrillo JI, Ritchie C, Rojkova K, Broich K, et al. PRECISION MEDICINE - the golden gate for detection, treatment and prevention of Alzheimer's disease. J Prev Alzheimers Dis. 2016;3(4):243\u201359.","journal-title":"J Prev Alzheimers Dis"},{"issue":"9","key":"589_CR69","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1158\/1078-0432.CCR-15-0426","volume":"21","author":"LA Chantrill","year":"2015","unstructured":"Chantrill LA, Nagrial AM, Watson C, Johns AL, Martyn-Smith M, Simpson S, et al. Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial. Clin Cancer Res. 2015;21(9):2029\u201337.","journal-title":"Clin Cancer Res"},{"key":"589_CR70","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.diabres.2016.04.033","volume":"117","author":"AJ Scheen","year":"2016","unstructured":"Scheen AJ. Precision medicine: the future in diabetes care? Diabetes Res Clin Pract. 2016;117:12\u201321.","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00589-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-020-00589-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00589-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T20:14:38Z","timestamp":1616789678000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00589-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,27]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00589-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,27]]},"assertion":[{"value":"13 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All contributing authors declare no potential competing interests. This study was approved by the Bedford VA Hospital Institutional Review Board. Access of administrative database for outpatient visit data and corresponding patients\u2019 prescription data was approved by the Bedford VA Hospital Institutional Review Board, Research and Development and the VA Informatics and Computing Infrastructure (VINCI) Resource Center. The content of the manuscript has not been published or submitted for publication elsewhere.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All contributing authors have approved the manuscript for submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}